About Genpathway
Genpathway is a company based in Carlsbad (United States) founded in 1999 was acquired by Active Motif in November 2010. Genpathway operates in a competitive market with competitors including Chroma Medicine, Reaction Biology, FOXO Technologies, Inherent Biosciences and Chronomics, among others.
- Headquarter Carlsbad, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Genpathway, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Active Motif
(Nov 12, 2010)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Genpathway
Detailed funding history for Genpathway
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Genpathway
Genpathway has secured backing from 1 investor. Prominent investors backing the company include Active Motif.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Epigenetics and gene regulation research tools are developed and distributed.
|
Locked | Locked | Locked |
Investor details for Genpathway
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Genpathway
Investment portfolio details for Genpathway
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Genpathway
Detailed financials for Genpathway
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Genpathway Comparisons
Peer comparison for Genpathway
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Genpathway
Genpathway operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Chroma Medicine, Reaction Biology, FOXO Technologies, Inherent Biosciences and Chronomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Epigenetic editing platform is developed for genomic medicines.
|
|
| Locked | Locked | Locked |
In vitro enzyme activity assays, secializing in kinase & epigenetic HTS and profiling
|
|
| Locked | Locked | Locked |
Epigenetic biomarkers are discovered and developed via AI platforms.
|
|
| Locked | Locked | Locked |
Epigenetic diagnostics and therapeutics for complex diseases are developed.
|
|
| Locked | Locked | Locked |
Proactive healthcare analysis is enabled by DNA-based epigenetic tests.
|
|
| Locked | Locked | Locked |
Epigenetic kits, reagents, and assays are supplied for research applications.
|
Detailed competitors of Genpathway
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Genpathway
Complete news archive for Genpathway
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genpathway
Genpathway was founded in 1999.
Genpathway is headquartered in Carlsbad, United States. It is registered at Carlsbad, California, United States.
Founded in 1999 in Carlsbad, United States, Genpathway operated in the systems biology sector with a focus on epigenetics. Products such as FactorPath for transcription-factor binding sites, TranscriptionPath for transcribed genes, HistonePath for histone sites, PromoterPath for promoters, and MethylPath for methylated regions were developed. Antibody qualification services for ChIP sequencing were also provided. Acquisition by Active Motif occurred in November 2010 for an undisclosed amount.
Genpathway's top competitors include Chroma Medicine, FOXO Technologies and EpiCypher.
Genpathway has 1 investor. Key investors include Active Motif.